Brief: Hamlet Pharma: new patent for treatment of colon cancer

Hamlet BioPharma AB

07/11/2017 08:10

Nov 7 (Reuters) - HAMLET PHARMA AB  HAMLET.ST  
    * NEW PATENT TO TREAT AND PREVENT GASTROINTESTINAL CANCER 
IS IN 
ORDER FOR GRANT 
    * PATENT APPLICATION  INCLUDES CLAIMS WHERE COMPLEXES 
INCLUDING 
HAMLET ARE USED FOR TREATMENT OF COLON CANCER 
 
Source text for Eikon:  ID:nNDL3m0t0D  
Further company coverage:  HAMLET.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))